logo
ScreenersREIT EarningsREIT SectorsMarketplaceLearn
Logo

Fulgent Genetics, Inc.

FLGT

Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions; solid tumor molecular profiling for somatic cancerā€¦ read more

Healthcare

Diagnostics & Research

7 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$21.52

Price

+1.22%

$0.26

$21.26

Previous Close

$21.20

Open

Premium

52w Discount
Market Cap

$658.706m

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$303.223m

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$51.023m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

-$1.04

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$1.112b

$1.200b

Assets

$88.202m

Liabilities

$7.386m

Debt
Debt to Assets

0.6%

-0.2x

Debt to EBITDA
Free Cash Flow

-$59.952m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
ā†‘ TopSummaryPriceFinancialsPress Releases
logo
About usFAQ
All the information presented is collected from official and public documents such as: Quarterly and Annual Reports, 10-K (US), Information Form (Canada), Presentations and the Investor Relations (IR) section of the company's website.
The data displayed by alreits.com is solely for informational purposes, we do not recommend the buying, holding or selling of any of the stocks on the website. If you have no experience in the stock market, please talk to your personal licensed investment advisor before making any decisions.